Dr. Morepen launches Rs. 499 annual multivitamin pack on Labour’s Day
Priced at just Rs. 499 for 1-year supply, this initiative is aligned with the vision of Health for All
Priced at just Rs. 499 for 1-year supply, this initiative is aligned with the vision of Health for All
Merck Wilmington Biotech will serve as a launch and commercial production facility and the future U.S. home for KEYTRUDA
Dasatinib Tablets is indicated for the treatment of (i) newly diagnosed adults with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia
The capital raise will also support debt repayment or prepayment, improving the company's debt-to-equity ratio and overall financial resilience
The merged entity ‘Aster DM Quality Care’ will be jointly controlled by Aster Promoters and Blackstone
Rising demands and advancements in eye care drive growth
More than 40 types of Amyloid proteins are discovered till date
The product will be launched in Q1FY26
The supply of these goods is set to commence within the first quarter of FY26
The company is targeting a Rs. 1,000 crore finished dosages business within the next five years
Subscribe To Our Newsletter & Stay Updated